Literature DB >> 25120143

From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.

Ralf J Ludwig1, Luca Borradori2, Luis A Diaz3, Takashi Hashimoto4, Michael Hertl5, Saleh M Ibrahim1, Marcel F Jonkman6, Yasuo Kitajima7, Dédée F Murrell8, Enno Schmidt1, Hiroshi Shimizu9, John R Stanley10, David T Woodley11, Detlef Zillikens12.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25120143     DOI： 10.1038/jid.2014.171

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  22 in total

1.  IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion.

Authors:  David Rafei; Ralf Müller; Norito Ishii; Maria Llamazares; Takashi Hashimoto; Michael Hertl; Rüdiger Eming
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid.

Authors:  Kelly N Messingham; Rupasree Srikantha; Amy M DeGueme; Janet A Fairley
Journal:  J Immunol       Date:  2011-06-06       Impact factor: 5.422

Review 3.  Emerging treatments for pemphigoid diseases.

Authors:  Ralf J Ludwig; Kathrin Kalies; Jörg Köhl; Detlef Zillikens; Enno Schmidt
Journal:  Trends Mol Med       Date:  2013-07-04       Impact factor: 11.951

Review 4.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

5.  Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.

Authors:  Volker Spindler; Vera Rötzer; Carina Dehner; Bettina Kempf; Martin Gliem; Mariya Radeva; Eva Hartlieb; Gregory S Harms; Enno Schmidt; Jens Waschke
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

6.  IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.

Authors:  D A M Oktarina; G van der Wier; G F H Diercks; M F Jonkman; H H Pas
Journal:  Br J Dermatol       Date:  2011-09       Impact factor: 9.302

7.  Humanization of autoantigen.

Authors:  Wataru Nishie; Daisuke Sawamura; Maki Goto; Kei Ito; Akihiko Shibaki; James R McMillan; Kaori Sakai; Hideki Nakamura; Edit Olasz; Kim B Yancey; Masashi Akiyama; Hiroshi Shimizu
Journal:  Nat Med       Date:  2007-02-25       Impact factor: 53.440

8.  Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita.

Authors:  Zlatko Kopecki; Nadira Ruzehaji; Christopher Turner; Hioraki Iwata; Ralf J Ludwig; Detlef Zillikens; Dedee F Murrell; Allison J Cowin
Journal:  J Invest Dermatol       Date:  2012-12-06       Impact factor: 8.551

9.  Anti-laminin gamma-1 pemphigoid.

Authors:  Teruki Dainichi; Sadamu Kurono; Bungo Ohyama; Norito Ishii; Noriko Sanzen; Maria Hayashi; Chisei Shimono; Yukimasa Taniguchi; Hiroshi Koga; Tadashi Karashima; Shinichiro Yasumoto; Detlef Zillikens; Kiyotoshi Sekiguchi; Takashi Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

10.  Pemphigus vulgaris autoantibody profiling by proteomic technique.

Authors:  Mina Kalantari-Dehaghi; Grant J Anhalt; Michael J Camilleri; Alex I Chernyavsky; Sookhee Chun; Philip L Felgner; Algis Jasinskas; Kristin M Leiferman; Li Liang; Steve Marchenko; Rie Nakajima-Sasaki; Mark R Pittelkow; John J Zone; Sergei A Grando
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.